Kent meningitis outbreak driven by a ‘recently emerged' disease subtype

Person receives vaccine
Liudmila Chernetska / iStock / Getty Images Plus via Getty Images

The Kent meningitis outbreak was driven by a recently emerged strain of the disease, a lack of herd immunity and social mixing, the country’s health protection watchdog has said.

The UK Health Security Agency (UKHSA) confirmed in a technical briefing that the cases that have been typed have been shown to be a 'recently emerged' subtype of MenB which has been circulating in England since 2020.

But the genetic make-up of the outbreak bacteria is also ‘clearly distinct’ within this subtype and has multiple ‘potentially significant’ genetic differences when compared to other MenB bacteria, the agency added.

Related Article: Pharmacists concerned they will see ‘very little’ of contract funding boost

The UKHSA said that these differences must be evaluated to 'understand how they may change the behaviour of the bacteria'.

This, in addition to a lack of immunity in the affected population and environmental factors such as close contact, is most likely what caused the outbreak, UKHSA added.

The briefing said: ‘The outbreak of meningococcal disease in Kent is unusual in size and pace compared to past outbreaks.

‘The drivers of the outbreak may be social and environmental factors, bacterial strain, or population immunity, or a combination of these.

‘Understanding the drivers will help us to choose the right public health measures to prevent further cases and outbreaks.

'It is highly likely that all of these factors are contributing to some degree.’

Related Article: Expansion of Pharmacy First a ‘key step’ in delivering preventative care

The agency worked with academic experts from across the UK to produce the new briefing following the first week of the disease outbreak and it includes early evidence and preliminary analyses which the UKHSA stressed may be subject to change.

Professor Robin May, chief scientific officer at the UKHSA, said: ‘This preliminary analysis offers strong reassurance that our existing vaccinations and antibiotic treatment offer will be effective against this strain.

‘In collaboration with the research community, we will continue intensive laboratory investigations of the strain to determine how the spread of the outbreak may have been influenced by the bacterial strain, social or environmental conditions, and population immunity.’

No new cases have been confirmed since yesterday, with the total number of confirmed cases remaining at 20 –with three other cases still under investigation.

Related Article: Beyond the scales: reframing eating disorder recognition in primary care

More than 10,000 MenB vaccines and almost 14,000 doses of antibiotics have been given out so far to people who are eligible to receive them, according to NHS Kent and Medway.

Ministers have also agreed that vaccination will be extended to include year 11s in schools where the vaccination offer has already been made. The UKHSA stressed that this is a ‘precautionary measure’ to ensure longer-term protection and minimise disruption to school attendance.

Want news like this straight to your inbox?
Register for full access to the site and our bulletins
Have your say

Leave a Reply

Your email address will not be published. Required fields are marked *

Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.